Sophia Humphreys, PharmD, MHA, BCBBS, spoke about how she views formulary management as a team approach.
Sophia Humphreys, PharmD, MHA, BCBBS, director of system pharmacy formulary management and clinical programs at Sutter Health and clinical assistant professor, University of Washington School of Pharmacy, talked about how multiple departments can work together for formulary management.
Transcript
How important is teamwork in formulary management?
So I see formulary management as a whole team approach. There's an old saying, "It takes a village"; with formulary management, you can only rely on 1 particular group. For example, when we evaluate 1 subclass of medication treatment, if you wanted to work on a new treatment for Alzheimer's disease, you have to involve your local clinical experts and your physician frontline experts, who are actually treating these patients, who are actually monitoring these patients—you would love to have their input. And in the meantime, you want to have your formulary experts, usually, they are PharmDs, they would do clinical evaluations, they will do drug information study, they will evaluate the efficacy, safety, and tolerability of these treatments. Also, we need to work with our hospital CEOs and hospital CMOs (chief medical officers), [and] our hospital DOPs, which is the director of pharmacy, to work on operations of these particular treatments. Some treatments would require different baseline labs and monitoring. Some of them require ongoing monitoring, which involves lab, involves imaging. And after all of the clinical data are evaluated, we also wanted to work with our supply chain experts to secure contracting for our patients, for our system, as well as payers, and medication informatics, and as well as finance and legal teams.
So really within each IDN (integrated delivery network), formulary management really requires a systematic and integrated approach. And in the meantime, we also work with external partners such as professional associations, foundations to support our patients, and also our drug companies sometimes offer patient assistance, and sometimes offer information that we cannot obtain from [a] published channel. Those would help our pharmacists and our physicians to evaluate the needs for the patients and to have a more comprehensive approach when we manage a complicated disease state and when we make formulary decisions.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
Advancements in Diabetes Technology: Coverage, Challenges, and Pregnancy Considerations
February 15th 2024Expert interviews highlight advancements and challenges in diabetes care technology, including automated insulin delivery systems and continuous glucose monitors, as well as improvements in insurance coverage.
Read More
How Health Care Institutions Can Leverage Biosimilars to Generate Savings
August 17th 2022On this episode of Managed Care Cast, Ryan Haumschild, PharmD, MS, MBA, from Emory Healthcare and the Winship Cancer Institute, explains the evolution of biosimilar pharmacoeconomics and the different strategies that health care institutions can implement to reap the benefits of biosimilar savings.
Listen
Diabetes Management During Pregnancy: Insights From 3 Specialists
February 8th 2024Experts explain how diabetes is diagnosed during pregnancy, how treatment differs from that of nonpregnant individuals, the importance of diabetes technology education, and how things change postpartum.
Read More
Top 5 Content From Institute for Value-Based Medicine® Events in 2023
December 27th 2023In 2023, there were 18 oncology and 7 population health Institute for Value-Based Medicine® events cohosted with organizations such as Optum, OneOncology, Vanderbilt Ingram Cancer Center, Duke Health, Cleveland Clinic, and Memorial Sloan Kettering Cancer Center.
Read More